Hydlieva 500mg Capsule: Potent Antineoplastic Therapy for Hematologic and Solid Tumor Management Are you searching for a reliable Hydlieva 500mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced cytotoxic therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Hydlieva 500mg? Hydlieva 500mg is an oral antineoplastic (anti-cancer) therapy containing the active pharmaceutical ingredient Hydroxyurea (also known as Hydroxycarbamide). Manufactured by Allieva Pharma Pvt Ltd, this 500mg capsule is a versatile antimetabolite used to treat a variety of proliferative disorders. It is a vital component in managing both malignant blood cancers and certain non-cancerous blood conditions. 1. Therapeutic Indications Chronic Myeloid Leukemia (CML): Specifically for resistant cases to help control the overproduction of white blood cells. Head and Neck Cancers: Used in combination with radiotherapy for locally advanced squamous cell carcinomas (excluding the lip). Sickle Cell Anemia: Indicated to reduce the frequency of painful crises and the need for blood transfusions in adult and pediatric patients. Polycythemia Vera & Essential Thrombocythemia: Used to manage excessive production of red blood cells and platelets, reducing the risk of blood clots and stroke. Cervical Cancer: Occasionally utilized as a radiosensitizer in comprehensive treatment protocols. 2. Mechanism of Action: Ribonucleotide Reductase Inhibition DNA Synthesis Inhibition: It acts as a potent inhibitor of the enzyme ribonucleotide reductase. This enzyme is essential for converting ribonucleotides into deoxyribonucleotides (the building blocks of DNA). S-Phase Specificity: By blocking DNA synthesis, Hydlieva prevents cancer cells from replicating their genetic material, halting them in the S-phase of the cell cycle. Fetal Hemoglobin Induction: In sickle cell disease, it increases the production of fetal hemoglobin (HbF), which prevents red blood cells from “sickling“ and improves oxygen transport. 3. Administration and Dosage Management Standard Dosing: The dose is highly individualized based on the patient's body weight, blood counts, and the specific condition being treated. Administration: Capsules should be swallowed whole. If the patient cannot swallow them, the contents may be dissolved in a glass of water and taken immediately. Safety Handling: As a cytotoxic agent, caregivers should wear disposable gloves when handling the capsules or powder to avoid direct skin contact. Clinical Side Effects & Safety Monitoring Bone Marrow Suppression: The most significant risk is a drop in white blood cells (leukopenia), platelets (thrombocytopenia), and red blood cells (anemia). Regular blood counts are mandatory. Cutaneous Toxicities: Potential for skin ulcers, darkening of the skin or nails, and in rare cases, secondary skin cancers (monitoring and sun protection are advised). Gastrointestinal Health: Nausea, vomiting, diarrhea, and mouth sores (stomatitis) are common side effects. Pulmonary Monitoring: Rare cases of interstitial lung disease or fibrosis have been reported; patients should report any new shortness of breath. Why Source Hydlieva 500mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Hydlieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us